IPO Plus

₹5,597.5

▼ -99.12 -1.74%

06 Aug 2026

NSE Listed · Pharmaceuticals

Alkem Laboratories Ltd. (ALKEM)

Volume: 1,09,477Avg Vol 1W: 95,007Avg Vol 1M: 1,22,46952W Range:₹4,738.5₹5,933.5
NSE BSE www.alkemlabs.com AI Report
Key Ratios
Checked just now
Market Cap₹66,927 Cr
Current Price₹5,597.5
Previous Close₹5,696.62
High / Low (52w)₹5,933.5 / ₹4,738.5
Volume1,09,477
Avg Vol (1W)95,007
Avg Vol (1M)1,22,469
Stock P/E283.13
Book Value₹1,156.01
Dividend Yield1%
ROE16.66%
ROA11.27%
Revenue (TTM)—
Revenue Growth2.34%
Profit Margin15.65%
Total Debt₹311 Cr
Shares Outstanding12 Cr
Face Value₹2
EPS (TTM)₹19.77
P/B4.84
Debt / Equity0.15
50 DMA₹5,510.06
200 DMA₹5,545.63
Day change-1.74%
Price Chart
₹5,597.5▲ 14.91% · 1Y
₹5890₹476414.0L
2025-08-06
2026-08-06

20-day avg volume: 1.3L shares

Pros
  • Healthy return on equity of 16.7%.
  • Company is almost debt-free.
  • Revenue grew 577% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 283.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹3,032 Cr₹3,415 Cr₹3,374 Cr₹3,144 Cr₹3,371 Cr₹4,001 Cr₹3,737 Cr₹3,603 Cr
EBITDA₹648 Cr₹808 Cr₹767 Cr₹425 Cr₹788 Cr₹931 Cr₹876 Cr₹612 Cr
Net Profit₹545 Cr₹689 Cr₹626 Cr₹306 Cr₹664 Cr₹765 Cr₹636 Cr₹236 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹2,287 Cr₹13,458 Cr₹2,045 Cr₹2,372 Cr₹2,542 Cr₹2,491 Cr₹15,296 Cr₹2,258 Cr
EBITDA₹759 Cr₹2,649 Cr₹317 Cr₹678 Cr₹813 Cr₹760 Cr₹3,207 Cr₹472 Cr
Net Profit₹723 Cr₹2,165 Cr₹277 Cr₹656 Cr₹787 Cr₹622 Cr₹2,302 Cr₹217 Cr
EPS—181.11————192.51—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹8,208 Cr₹9,946 Cr₹11,519 Cr₹14,069 Cr₹13,757 Cr₹15,575 Cr₹17,691 Cr₹20,873 Cr
Total Liabilities₹2,636 Cr₹3,637 Cr₹3,961 Cr₹5,222 Cr₹4,322 Cr₹4,861 Cr₹5,257 Cr₹6,524 Cr
Equity₹5,572 Cr₹6,309 Cr₹7,558 Cr₹8,847 Cr₹9,435 Cr₹10,714 Cr₹12,434 Cr₹14,349 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1,029 Cr₹868 Cr₹1,666 Cr₹1,508 Cr₹1,956 Cr₹2,355 Cr₹2,417 Cr₹2,592 Cr
Investing₹-314 Cr₹-741 Cr₹-999 Cr₹-1,435 Cr₹113 Cr₹-1,008 Cr₹-1,299 Cr₹-1,667 Cr
Financing₹-379 Cr₹79 Cr₹-272 Cr₹380 Cr₹-1,761 Cr₹-1,145 Cr₹-811 Cr₹-503 Cr
Free Cash Flow₹1,029 Cr₹868 Cr₹1,666 Cr₹1,508 Cr₹1,956 Cr₹2,355 Cr₹2,417 Cr₹2,592 Cr
Shareholding
Promoter 49.7% Institutions 33.05% Public 17.25%
Efficiency & Working Capital
ROCE20.3%
Interest Coverage18.9
Dividend Payout—
Debtor Days74 d
Inventory Days83 d
Payable Days56 d
Cash Conversion Cycle101 d
Working Capital Days157 d
Shareholding Details

As of 2026-06-30

Promoter49.7%
FII10.4%
DII22.6%
Institutions33%
Public17.3%
Promoter Pledge0%
No. of Shareholders62,822
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters56.7%56.7%56.7%56.4%55.7%55.7%55.1%53%51.2%51.2%51.2%49.7%
FIIs6%8.5%9.1%8.7%9%10.1%9.4%9.1%9.5%10%10.2%10.4%
DIIs17.6%14.9%15.6%18.6%19.2%18%19.4%21.8%21.9%21.5%21.4%22.6%
Public19.6%19.8%18.5%16.4%16.1%16.2%16%16.1%17.4%17.3%17.2%17.3%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders69,44265,18465,83069,62774,74484,03884,32679,74067,19664,53662,83562,822
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Sarandhar Singh * (please Refer Notes)Shareholding of Promoter and Promoter Group18.3%2.19 Cr
Basudeo Narain SinghShareholding of Promoter and Promoter Group7.3%86,95,360
Mritunjay Kumar SinghShareholding of Promoter and Promoter Group6.4%76,82,000
Madhurima Singh& (please Refer Notes)Shareholding of Promoter and Promoter Group6.2%73,93,939
Hdfc Mutual Fund - Hdfc Mid-cap FundPublic Shareholding4.8%57,06,750
Icici Prudential Multi-asset FundPublic Shareholding3.6%42,68,472
Madhurima Singh@ (please Refer Notes)Shareholding of Promoter and Promoter Group2.6%30,92,875
Kishor Kumar SinghPublic Shareholding2.5%29,73,312
Alok KumarPublic Shareholding2.3%27,64,719
Ashok KumarPublic Shareholding2.3%26,88,000
Seema SinghShareholding of Promoter and Promoter Group2.2%25,79,045
Deepak Kumar SinghPublic Shareholding2%24,02,140
Archana SinghShareholding of Promoter and Promoter Group2%23,94,050
Sbi Large & Midcap FundPublic Shareholding2%23,83,162
Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap FundPublic Shareholding1.9%22,34,434
Dsp Midcap FundPublic Shareholding1.8%21,32,118
Nps Trust- A/c Hdfc Pension Fund Management Limited Scheme E - Tier IPublic Shareholding1.5%17,41,075
Life Insurance Corporation Of India - P & Gs FundPublic Shareholding1.4%17,15,063
Rajesh KumarPublic Shareholding1.4%16,84,535
Hdfc Life Insurance Company LimitedPublic Shareholding1.3%15,60,875
Rajeev RanjanPublic Shareholding1.2%14,85,342
Aniruddha Singh& (please Refer Notes)Shareholding of Promoter and Promoter Group1%12,08,971
Divya Singh& (please Refer Notes)Shareholding of Promoter and Promoter Group1%12,08,971
Meghna SinghShareholding of Promoter and Promoter Group1%12,08,650
Shrey Shree Anant SinghShareholding of Promoter and Promoter Group1%11,95,650
Board of Directors
NameDesignationYear
Basudeo N SinghExecutive Chairman2025
SANDEEP SINGHManaging Director2025
Mritunjay Kumar SinghExecutive Director2025
Manish NarangCompany Sec. & Compli. Officer2025
Narendra AnejaIndependent Director2025
SARVESH SINGHExecutive Director2025
Madhurima SinghExecutive Director2025
Sujjain TalwarIndependent Director2025
Srinivas SinghExecutive Director2025
Rajeev KherIndependent Director2025
Ranjal Laxmana ShenoyIndependent Director2025
Neela BhattacherjeeIndependent Director2025
Diwakar GuptaIndependent Director2025
Segments — Product
SegmentRevenueShare
Pharma Business₹2,708 Cr100%
Others (Investing & Real Estate)₹0 Cr0%
Segments — Geography
RegionRevenueShare
India₹7,023 Cr72.7%
USA₹1,617 Cr16.7%
Other Countries₹1,024 Cr10.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2502424
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings—
forthcoming2026-08-07Dividend (10/- per share)Final
dividend2026-08-07₹10 (500%)Final
dividend2026-02-20₹43 (2150%)Interim
dividend2025-08-08₹8 (400%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20254,649139018605,056
20251,66700001,667
2025300003
Insider / Designated-Person Trades

17 recent disclosure(s)

Mr. Deepak Kumar SinghDisposal · 25,000
Mritunjay Kumar SinghAcquisition · 1,643
Mritunjay Kumar SinghAcquisition · 3,357
Dhananjay and Madhurima Singh TrustAcquisition · 1,050
Dhananjay and Madhurima Singh TrustAcquisition · 2,000
Mr. Deepak Kumar SinghDisposal · 2,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market04/06/2025 · 8,70,228
Company Information
Incorporated1973
ChairmanBasudeo N Singh
AuditorDeloitte Haskins & Sells LLP/B S R & Co LLP
Investor Email[email protected] ; [email protected]
🌐 www.alkemlabs.com ↗

📍 Alkem House SenapatiBapat Marg, Lower Parel, Mumbai, Maharashtra, 400013

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Alcokraft Distillerie Ltd.Alembic LimitedAlgoquant Fintech LimitedAlicon Castalloy LimitedAlivus Life Sciences Ltd.Alkali Metals Ltd.Alkyl Amines Chemicals Ltd.Allcargo Logistics Ltd.Alldigi Tech LimitedAll E Technologies Ltd.All Time Plastics LimitedAlmondz Global Securities Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App